Outcomes of HPV-Associated Squamous Cell Carcinoma of the Head and Neck: Impact of Race and Socioeconomic Status

被引:30
|
作者
Pike, Luke R. G. [1 ]
Royce, Trevor J. [2 ]
Mahal, Amandeep R. [3 ]
Kim, Daniel W. [1 ]
Hwang, William L. [1 ]
Mahal, Brandon A. [1 ]
Sanford, Nina N. [4 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, 55 Fruit St, Boston, MA 02114 USA
[2] Univ N Carolina, Dept Radiat Oncol, Sch Med, Chapel Hill, NC 27515 USA
[3] Yale Univ, Sch Med, New Haven, CT USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA
关键词
HUMAN-PAPILLOMAVIRUS; MARITAL-STATUS; OROPHARYNX CANCER; SURVIVAL; TRENDS; SMOKING; RISK; SEX;
D O I
10.6004/jnccn.2019.7356
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Socioeconomic factors affecting outcomes of HPV-associated squamous cell carcinoma of the head and neck (SCCHN) are poorly characterized. Methods: A custom SEER database identified adult patients with primary nonmetastatic SCCHN and known HPV status diagnosed in 2013 through 2014. Multivariable logistic regression defined associations between patient characteristics and HPV status, with adjusted odds ratios (aORs) and 95% confidence intervals reported. Fine-Gray competing risks regression estimated adjusted hazard ratios (aHRs) and 95% confidence intervals for cancer-specific mortality (CSM), including a disease subsite * HPV status * race interaction term. Results: A total of 4,735 patients with nonmetastatic SCCHN and known HPV status were identified. HPV-associated SCCHN was positively associated with an oropharyngeal primary, male sex, and higher education, and negatively associated with uninsured status, single marital status, and nonwhite race (P <= .01 for all). For HPV-positive oropharyngeal SCCHN, white race was associated with lower CSM (aHR, 0.55; 95% CI, 0.34-0.88; P=.01) and uninsured status was associated with higher CSM (aHR, 3.12; 95% CI, 1.19-8.13; P=.02). These associations were not observed in HPV-negative or nonoropharynx SCCHN. Accordingly, there was a statistically significant disease subsite * HPV status * race interaction (P-interaction < .001). Conclusions: Nonwhite race and uninsured status were associated with worse CSM in HPV-positive oropharyngeal SCCHN, whereas no such associations were observed in HPV-negative or nonoropharyngeal SCCHN. These results suggest that despite having clinically favorable disease, nonwhite patients with HPV-positive oropharyngeal SCCHN have worse outcomes than their white peers. Further work is needed to understand and reduce socioeconomic disparities in SCCHN.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [41] Is p16 Better and More Cost Effective Than HPV ISH for Detection of HPV-Associated Head and Neck Squamous Cell Carcinoma?
    Primeaux, T. M.
    Thomas, J.
    MODERN PATHOLOGY, 2011, 24 : 282A - 282A
  • [42] Biomarkers of HPV in Head and Neck Squamous Cell Carcinoma
    Liang, Caihua
    Marsit, Carmen J.
    McClean, Michael D.
    Nelson, Heather H.
    Christensen, Brock C.
    Haddad, Robert I.
    Clark, John R.
    Wein, Richard O.
    Grillone, Gregory A.
    Houseman, E. Andres
    Halec, Gordana
    Waterboer, Tim
    Pawlita, Michael
    Krane, Jeffrey F.
    Kelsey, Karl T.
    CANCER RESEARCH, 2012, 72 (19) : 5004 - 5013
  • [43] Biomarkers of HPV in head and neck squamous cell carcinoma
    Liang, Caihua
    Marsit, Carmen J.
    McClean, Michael D.
    Nelson, Heather H.
    Christensen, Brock C.
    Haddad, Robert I.
    Clark, John R.
    Wein, Richard O.
    Grillone, Gregory A.
    Houseman, E. Andres
    Halec, Gordana
    Waterboer, Tim
    Pawlita, Michael
    Krane, Jeffrey
    Kelsey, Karl T.
    CANCER RESEARCH, 2012, 72
  • [44] Characteristics and Impact of HPV to Head and Neck Squamous Cell Carcinoma in Thai Patients
    Jiarpinitnun, C.
    Pattaranutaporn, P.
    Larbcharoensub, N.
    Chureemas, T.
    Juengsamarn, J.
    Trachu, N.
    Lukerak, S.
    Chansriwong, P.
    Ngamphaiboon, N.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S579 - S579
  • [45] Is p16 Better and More Cost Effective Than HPV ISH for Detection of HPV-Associated Head and Neck Squamous Cell Carcinoma?
    Primeaux, T. M.
    Thomas, J.
    LABORATORY INVESTIGATION, 2011, 91 : 282A - 282A
  • [46] Role of Cytology in the Diagnosis and Management of HPV-Associated Head and Neck Carcinoma
    Krane, Jeffrey F.
    ACTA CYTOLOGICA, 2013, 57 (02) : 117 - 126
  • [47] Advances in Surgical Therapy for HPV-Associated Squamous Cell Carcinoma
    Collin F. Mulcahy
    Neil D. Gross
    Current Otorhinolaryngology Reports, 2022, 10 : 475 - 482
  • [48] Treatment of Recurrent and Metastatic HPV-Associated Squamous Cell Carcinoma
    Wotman, Michael
    Gold, Brandon
    Takahashi, Mai
    Draper, Lindsey
    Posner, Marshall
    CURRENT OTORHINOLARYNGOLOGY REPORTS, 2022, 10 (02) : 208 - 217
  • [49] Treatment of Recurrent and Metastatic HPV-Associated Squamous Cell Carcinoma
    Michael Wotman
    Brandon Gold
    Mai Takahashi
    Lindsey Draper
    Marshall Posner
    Current Otorhinolaryngology Reports, 2022, 10 : 208 - 217
  • [50] Concurrent immunoradiation for HPV-associated oropharyngeal squamous cell carcinoma
    Raj Singh
    John Austin Vargo
    Shiyu Song
    European Archives of Oto-Rhino-Laryngology, 2023, 280 : 797 - 809